Active Shortage

JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE in Canada?

Yes. JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 12.5MG 150MG has an active shortage reported to Health Canada (last updated April 5, 2021).

Why is JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE be available again?

The estimated resolution date (December 30, 2022) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength12.5MG 150MG

Last updated2021-04-05

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2022-12-30

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02418223

Strength

12.5MG 150MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE IRBESARTAN

Tier

Unrated

Last Updated

2021-04-05

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE has 2 shortage/discontinuation reports on file — this is one of them.

2021-04-07

Active Shortage

Disruption of the manufacture of the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225

AMLODIPINE

5MG · DIN 02429217